title: Substance P, insulinlike growth factor 1, and surface healing.
authors.affiliation: Department of Ophthalmology and Visual Sciences, University of Wisconsin, 2870 University Ave, Suite 206, Madison, WI 53705, USA.
authors.forename: Catherine H
authors.initials: CH
authors.lastname: Lee
authors.forename: Amanda L
authors.initials: AL
authors.lastname: Whiteman
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Murphy
authors.forename: Neal P
authors.initials: NP
authors.lastname: Barney
authors.forename: Peter B
authors.initials: PB
authors.lastname: Taylor
authors.forename: Ted W
authors.initials: TW
authors.lastname: Reid
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D000068438:Brimonidine Tartrate; D003316:Corneal Diseases / Q000188:drug therapy* / Q000209:etiology; D004359:Drug Therapy, Combination; D019573:Epithelium, Corneal / Q000187:drug effects* / Q000473:pathology; D005260:Female; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000008:administration & dosage / Q000627:therapeutic use*; D015948:Keratoplasty, Penetrating / Q000009:adverse effects; D009883:Ophthalmic Solutions; D011112:Polymyxin B / Q000627:therapeutic use; D011810:Quinoxalines / Q000627:therapeutic use; D013373:Substance P / Q000008:administration & dosage / Q000627:therapeutic use*; D014945:Wound Healing / Q000187:drug effects*
chemical_list: D000900:Anti-Bacterial Agents; D000959:Antihypertensive Agents; D009883:Ophthalmic Solutions; D011810:Quinoxalines; D013373:Substance P; D000068438:Brimonidine Tartrate; D007334:Insulin-Like Growth Factor I; D011112:Polymyxin B